Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.
Also called NCT01858428
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT01858428
-
- Other papers using this trial's data
- Stellarex Drug-Coated Balloon for the Treatment of Peripheral Artery Disease: Five-Year Results from the ILLUMENATE Pivotal Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria
- Registry status
- Completed
Technical summary
Registry record NCT01858428. Randomized; single masking; primary purpose treatment. Start 2013-06-18 (actual); primary completion 2016-09 (actual). Results posted on 2018-01-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon
- Acronym
- ILLUMENATE
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- Cardiovascular Ingenuity (CVI) Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter
- Intervention (Device)
- EverCross Percutaneous Transluminal Balloon Catheter
- Lead sponsor
- Spectranetics Corporation
Record details
- Record id
cardio:ct-nct01858428- Content hash
29fc8dec1704051ea540d3d70ff46d763d5ecbe808338066572024472d6cb050